About Abcuro
abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic t and nk cells that express the inhibitory immune ... Read more
abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic t and nk cells that express the inhibitory immune ... Read more